BIM
BMY icon

Bogle Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bogle Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-249,815
Closed -$13M – 289
2018
Q4 		$13M Buy
+249,815
New +$13.4M 1.01% 7
2018
Q3 		– Sell
-80,787
Closed -$4.47M – 275
2018
Q2 		$4.47M Buy
+80,787
New +$4.36M 0.32% 106
2017
Q1 		– Sell
-217,433
Closed -$12.7M – 310
2016
Q4 		$12.7M Buy
+217,433
New +$11.9M 0.88% 23

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bogle Investment Management's BMY Position: Q1 2019 in Review

Bogle Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 249,815 shares — an estimated $13M sold.

Bogle Investment Management first reported a position in BMY in Q4 2016 and held it in 3 quarters. The position peaked at $13M in Q4 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Bogle Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Bogle Investment Management sold 249,815 Bristol-Myers Squibb shares in Q1 2019, an estimated $13M.
  • Bogle Investment Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 3 quarters.
  • Bogle Investment Management's Bristol-Myers Squibb position peaked at $13M in Q4 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Bogle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.